(1-(tetrahydro-2H-pyran-2-yl)-5-(trifluoromethyl)-1H-indazol-4-yl)boronic acid – (2374153-25-8)

Pomalidomide-PEG6-Butyl Iodide, 1835705-74-2, Pomalidomide-PEG2-Butyl Iodide, 1835705-72-0, Pomalidomide-2-2-6-I, N-(2-(2, 6-Dioxopiperidin-3-yl)-1, 3-dioxoisoindolin-4-yl)-2-(2-((6-iodohexyl)oxy)ethoxy)acetamide, Pomalidomide-PEG6-butyliodide, SCHEMBL18788342, AKOS040743785, Pomalidomide-NH-CO-PEG2-butyl iodide, DA-76999, MS-31359, HY-136156, CS-0120073, E85783, N-[2-(2, 6-dioxo-3-piperidyl)-1, 3-dioxo-isoindolin-4-yl]-2-[2-[2-[2-[2-[2-(6-iodohexoxy)ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]acetamide, N-[2-(2, 6-dioxopiperidin-3-yl)-1, 3-dioxoisoindol-4-yl]-2-[2-[2-[2-[2-[2-(6-iodohexoxy)ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]acetamide